Soluble insulin receptor and metabolic syndrome

The metabolic syndrome describes a group of signs that increase the likelihood for developing type 2 diabetes mellitus, cardiovascular diseases and some types of cancer. The action of insulin depends on its binding to membrane receptors on its target cells. We wonder if blood insulin could travel bound to proteins and if, in the presence of hyperinsulinemia, a soluble insulin receptor might be generated. We used young adult Wistar rats (which have no predisposition to obesity or diabetes), whose drinking water was added 20 % of sugar and that were fed a standard diet ad libitum for two and six months. They were compared with control rats under the same conditions, but that had running water for consumption. At two months, the rats developed central obesity, moderate hypertension, high triglyceride levels, hyperinsulinemia, glucose intolerance and insulin resistance, i.e., metabolic syndrome. Electrophoresis of the rats’ plasma proteins was performed, followed by Western Blot (WB) for insulin and for the outer portion of the insulin receptor. The bands corresponding to insulin and to the receptor external part were at the same molecular weight level, 25-fold higher than that of free insulin. We demonstrated that insulin, both in control animals and in those with hyperinsulinemia, travels bound to the receptor outer portion (ectodomain), which we called soluble insulin receptor, and that is released al higher amounts in response to plasma insulin increase; in rats with metabolic syndrome and hyperinsulinemia, plasma levels are much higher than in controls. Soluble insulin receptor increase in blood might be an early sign of metabolic syndrome.

Saved in:
Bibliographic Details
Main Authors: Hiriart-Urdanivia,Marcia, Sánchez-Soto,Carmen, Velasco,Myrian, Sabido-Barrera,Jean, Ortiz-Huidobro,Rosa Isela
Format: Digital revista
Language:English
Published: Academia Nacional de Medicina de México A.C. 2019
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132019000500500
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0016-38132019000500500
record_format ojs
spelling oai:scielo:S0016-381320190005005002021-06-30Soluble insulin receptor and metabolic syndromeHiriart-Urdanivia,MarciaSánchez-Soto,CarmenVelasco,MyrianSabido-Barrera,JeanOrtiz-Huidobro,Rosa Isela Soluble insulin receptor Hyperinsulinemia Insulin resistance The metabolic syndrome describes a group of signs that increase the likelihood for developing type 2 diabetes mellitus, cardiovascular diseases and some types of cancer. The action of insulin depends on its binding to membrane receptors on its target cells. We wonder if blood insulin could travel bound to proteins and if, in the presence of hyperinsulinemia, a soluble insulin receptor might be generated. We used young adult Wistar rats (which have no predisposition to obesity or diabetes), whose drinking water was added 20 % of sugar and that were fed a standard diet ad libitum for two and six months. They were compared with control rats under the same conditions, but that had running water for consumption. At two months, the rats developed central obesity, moderate hypertension, high triglyceride levels, hyperinsulinemia, glucose intolerance and insulin resistance, i.e., metabolic syndrome. Electrophoresis of the rats’ plasma proteins was performed, followed by Western Blot (WB) for insulin and for the outer portion of the insulin receptor. The bands corresponding to insulin and to the receptor external part were at the same molecular weight level, 25-fold higher than that of free insulin. We demonstrated that insulin, both in control animals and in those with hyperinsulinemia, travels bound to the receptor outer portion (ectodomain), which we called soluble insulin receptor, and that is released al higher amounts in response to plasma insulin increase; in rats with metabolic syndrome and hyperinsulinemia, plasma levels are much higher than in controls. Soluble insulin receptor increase in blood might be an early sign of metabolic syndrome.info:eu-repo/semantics/openAccessAcademia Nacional de Medicina de México A.C.Gaceta médica de México v.155 n.5 20192019-10-01info:eu-repo/semantics/reporttext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132019000500500en10.24875/gmm.m20000339
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Hiriart-Urdanivia,Marcia
Sánchez-Soto,Carmen
Velasco,Myrian
Sabido-Barrera,Jean
Ortiz-Huidobro,Rosa Isela
spellingShingle Hiriart-Urdanivia,Marcia
Sánchez-Soto,Carmen
Velasco,Myrian
Sabido-Barrera,Jean
Ortiz-Huidobro,Rosa Isela
Soluble insulin receptor and metabolic syndrome
author_facet Hiriart-Urdanivia,Marcia
Sánchez-Soto,Carmen
Velasco,Myrian
Sabido-Barrera,Jean
Ortiz-Huidobro,Rosa Isela
author_sort Hiriart-Urdanivia,Marcia
title Soluble insulin receptor and metabolic syndrome
title_short Soluble insulin receptor and metabolic syndrome
title_full Soluble insulin receptor and metabolic syndrome
title_fullStr Soluble insulin receptor and metabolic syndrome
title_full_unstemmed Soluble insulin receptor and metabolic syndrome
title_sort soluble insulin receptor and metabolic syndrome
description The metabolic syndrome describes a group of signs that increase the likelihood for developing type 2 diabetes mellitus, cardiovascular diseases and some types of cancer. The action of insulin depends on its binding to membrane receptors on its target cells. We wonder if blood insulin could travel bound to proteins and if, in the presence of hyperinsulinemia, a soluble insulin receptor might be generated. We used young adult Wistar rats (which have no predisposition to obesity or diabetes), whose drinking water was added 20 % of sugar and that were fed a standard diet ad libitum for two and six months. They were compared with control rats under the same conditions, but that had running water for consumption. At two months, the rats developed central obesity, moderate hypertension, high triglyceride levels, hyperinsulinemia, glucose intolerance and insulin resistance, i.e., metabolic syndrome. Electrophoresis of the rats’ plasma proteins was performed, followed by Western Blot (WB) for insulin and for the outer portion of the insulin receptor. The bands corresponding to insulin and to the receptor external part were at the same molecular weight level, 25-fold higher than that of free insulin. We demonstrated that insulin, both in control animals and in those with hyperinsulinemia, travels bound to the receptor outer portion (ectodomain), which we called soluble insulin receptor, and that is released al higher amounts in response to plasma insulin increase; in rats with metabolic syndrome and hyperinsulinemia, plasma levels are much higher than in controls. Soluble insulin receptor increase in blood might be an early sign of metabolic syndrome.
publisher Academia Nacional de Medicina de México A.C.
publishDate 2019
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132019000500500
work_keys_str_mv AT hiriarturdaniviamarcia solubleinsulinreceptorandmetabolicsyndrome
AT sanchezsotocarmen solubleinsulinreceptorandmetabolicsyndrome
AT velascomyrian solubleinsulinreceptorandmetabolicsyndrome
AT sabidobarrerajean solubleinsulinreceptorandmetabolicsyndrome
AT ortizhuidobrorosaisela solubleinsulinreceptorandmetabolicsyndrome
_version_ 1756219494720602113